Systematic Review of Domperidone in Clinical Practice
WANG Yan,CHEN Shiyao,WU Lijun
DOI: https://doi.org/10.3969/j.issn.1008-7125.2011.04.009
2011-01-01
Abstract:Background: Although the clinical efficacy of domperidone has been widely evaluated,most studies have few samples and lack of representation,and the best medication approach and dosage are still uncertain.Aims: To systematically review the clinical application of domperidone.Methods: Databases including Evidence-Based Medicine Reviews,BIOSIS Previews,EMBASE Drugs & Pharmacology,Ovid MEDLINE,CBM,GJFD,VIP,ChinaInfo,and Dissertation of China were retrieved electronically to identify the parallel design randomized controlled trials(RCTs),which compared domperidone with placebo up to Dec.2007.Meta-analysis was conducted with RevMan 4.2.8 software.Results: Fourteen RCTs fulfilling the criteria were involved.Meta-analysis indicated that domperidone was effective in ameliorating overall symptoms(RR=1.77,95% CI: 1.30-2.42,P=0.0003),and the result was confirmed by sensitivity analysis.In subgroup analysis,it was demonstrated that domperidone could ameliorate functional dyspepsia symptoms(RR=2.75,95% CI: 1.27-5.95,P=0.01) and infant nausea and vomiting(RR=10.60,95% CI: 3.17-35.46,P=0.0001),but had no effect on postoperative nausea and vomiting(RR=1.12,95% CI: 0.86-1.45,P=0.41).Oral administration(RR=2.51,95% CI: 1.50-4.20,P=0.0005) was better than intravenous administration(RR=1.12,95% CI: 0.86-1.45,P=0.41),and high dose(20 mg tid,RR=4.67,95% CI: 2.30-9.48,P<0.0001) was better than low dose(10 mg tid,RR=2.20,95% CI: 0.77-6.27,P=0.14).Conclusions: This systematic review confirmed the remarkable clinical efficacy of domperidone.Although the optimal medication dosage remains to be defined,oral administration of a higher dose(20 mg tid) might be a better choice.